Fig. 7
Risk score analysis of the 6-metabolic-gene-signature related prognostic model in the test group and ICGC cohort. A Risk curve, survival scatter plot analysis and heat maps of expression profiles of 6 metabolic genes of patients with high- and low-risk in the testing set of the 6-gene signature prognosis model. B Kaplan–Meier curve shows the overall survival of high- and low-risk RCC patients in the testing set. C Time-dependent (ROC) curve analysis exhibits the prognostic performance of the 6-gene-signature-based prognostic model in predicting 1 ~ 5-year survival times of the testing set. D Risk curve, survival scatter plot analysis and heat maps of expression profiles of 6 metabolic genes of patients with high- and low-risk of the 6-gene-signature prognosis model in the ICGC RCC cohort. E Kaplan–Meier curve shows the overall survival of high- and low-risk RCC patients in the ICGC RCC cohort. F Time-dependent ROC curve analysis exhibits the prognostic performance of the 6-gene-signature-based prognostic model in predicting 1 ~ 5-year survival times of the ICGC RCC cohort